P3C030D05

Placa Pellicon^® 3 con membrana Ultracel^®

filtration area 0.57 m², NMWCO 30 kDa, Holdup volume 118 mL

• Sinónimos: Pellicon^® 3 Cassette with Ultracel 30 kDa Membrane, D screen, 0.57 m², Pellicon^® 3 Ultracel^® Membrane Cassette, Pellicon^® 3 Ultrafiltration Cassette
• eCl@ss: 32031602
• UNSPSC Code: 41104903

Propiedades

• Quality Segment: 400
• material: TPE seal, composite regenerated cellulose (CRC) , polypropylene screen, stainless steel cap (for end; polypropylene-encapsulated)
• sterility: non-sterile
• product line: Pellicon^®
• feature: holdup volume 118 mL (in feed channel)
• manufacturer/tradename: Pellicon^®
• parameter: 30 psi max. reverse press. exposure at 25 °C (for 24 hours), 4-6 L/min-m² recirculation rate, 40 psi max. transmembrane pressure at 4-50 °C, 6.9 bar max. inlet pressure (100 psi), 80 psi max. transmembrane pressure at 4-40 °C
• technique(s): analytical sample preparation: suitable, buffer exchange: suitable, protein purification: suitable (concentration), tangential flow filtration (TFF): suitable
• H: 2.6 cm (1.01 in.)
• L: 20.6 cm (8.1 in.)
• W: 17.8 cm (7 in.)
• filtration area: 0.57 m²
• membrane area: 0.57 m²
• gravimetric extractables: ≤1500 mg/m²
• matrix: Ultracel^® (Membrane)
• pore size: 30 kDa NMWCO
• pH: 2-13
• application(s): mAb; recombinant protein

Descripción

General description

The Pellicon^® 3 Cassette with Ultracel^® membrane is a high performance tangential flow filtration (TFF) device designed to support efficient ultrafiltration and diafiltration of therapeutic antibodies and other biologics. This cassette is manufactured for high product recovery, reliable flux performance, and robust cleanability. It reduces processing time while maintaining product quality. Its durable construction enables operation under demanding process conditions, including elevated pressures, and temperatures, making it an ideal choice for today′s high-titer bioprocessing applications.

Application

Pellicon^® 3 Cassettes with Ultracel^® 30kD Membrane D screen is manufactured to efficiently process high viscosity products. These cassettes can achieve higher concentration therapeutic protein formulations by maximizing mass transfer and managing the pressure drop created by higher viscosity. From process development through commercial production, these cassettes deliver reliable performance across various filtration applications, including:

• Monoclonal antibodies (mAbs)
• Recombinant and non-recombinant proteins
• Plasma
• Vaccine process streams

Features and Benefits

• Rugged & reliable – ideally suited for today′s more demanding filtration processes
• High performance – produces excellent resolution, yields and back-pressure resistance
• Optimum product recovery – thanks to proven membrane technology
• Void-free technology – leading-edge membranes resolve virtually any separation challenge
• Defect-free, superior adhesion – Ultracel^®uses composite membranes cast on a microporous substrate
• Automated manufacturing – delivers unbeatable performance, consistency and reliability
• Easy installation & care – simple to install and maintain

Analysis Note

Gravimetric Extractables: after 24 hours in water at controlled room temperature

Other Notes

These products are manufactured in a facility which adheres to Good Manufacturing Practices.

Legal Information

Pellicon is a registered trademark of Merck KGaA, Darmstadt, Germany

ULTRACEL is a registered trademark of Merck KGaA, Darmstadt, Germany

Información de seguridad

• Clase de almacenamiento: 10 - Combustible liquids
• WGK: WGK 2